Consistently, previous studies have demonstrated that CD44 and integrin β1 are co-enriched and colocalized in plasma membrane microdomains where they cooperate in regulating cancer cell motility [[38], [39], [40], [41]]. The gene discussed is CD44; the disease is cancer.